VERTEX PHARMACEUTICALS INC / MA Increase (Decrease) in Income Taxes Payable
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Increase (Decrease) in Income Taxes Payable of -$11.36 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2013-03-01
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in income taxes payable for the quarter ending 2012-12-31 was -$3.16M, a 236.03% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in income taxes payable for the quarter ending 2012-09-30 was $3.67M.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in income taxes payable for the quarter ending 2012-06-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in income taxes payable for the quarter ending 2012-03-31 was -$11.87M.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in income taxes payable for fiscal 2012 was -$11.36M, a 194.08% decline from fiscal 2011.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in income taxes payable for fiscal 2011 was $12.07M.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in income taxes payable for fiscal 2010 was $0.00.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $514.00K derived: sum of 2 quarters · filed 2013-03-01 | $514.00K derived: sum of 3 quarters · filed 2013-03-01 | -$11.36M 10-K · filed 2013-03-01 |
| 2012-09-30 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $3.67M derived: sum of 2 quarters · filed 2012-11-06 | -$8.20M 10-Q · filed 2012-11-06 | -$5.88M derived: sum of 4 quarters · filed 2013-03-01 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$11.87M 10-Q · filed 2012-08-08 | -$9.55M derived: sum of 3 quarters · filed 2013-03-01 | -$15.01M derived: sum of 4 quarters · filed 2013-03-01 |
| 2012-03-31 | -$11.87M 10-Q · filed 2012-05-10 | -$9.55M derived: sum of 2 quarters · filed 2013-03-01 | -$15.01M derived: sum of 3 quarters · filed 2013-03-01 | |
| 2011-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$3.14M derived: sum of 2 quarters · filed 2013-03-01 | $12.07M 10-K · filed 2013-03-01 | |
| 2011-09-30 | -$5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $9.76M 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $15.21M 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |